Back to History Current Version
Pregnancy Testing in Northern Uganda
Last registered on May 11, 2019


Trial Information
General Information
Pregnancy Testing in Northern Uganda
Initial registration date
July 29, 2018
Last updated
May 11, 2019 8:10 AM EDT
Primary Investigator
University of Illinois, Urbana-Champaign
Other Primary Investigator(s)
PI Affiliation
Harvard T.H.Chan School of Public Health
PI Affiliation
University of Illinois at Urbana-Champaign
Additional Trial Information
In development
Start date
End date
Secondary IDs
Given the high rate of delayed adoption of antenatal care (ANC), and high rates of unintended pregnancy and unsafe abortion in Uganda, research on the period of time before confirmation of pregnancy is critical to understand underlying beliefs that guide behaviors ultimately important for maternal and neonatal health.

Home pregnancy tests - which now cost less than 10 cents each - have the potential to facilitate FP uptake and significantly improve reproductive, maternal and child health outcomes in sub-Saharan Africa, including Uganda. These tests are easy to administer, disposable, inexpensive, and have a low false positive rate. Yet, for women living in rural areas in sub-Saharan countries, these tests are typically unavailable outside of health centers or they are prohibitively expensive.

This study will investigate women's underlying beliefs about pregnancy status and examine how providing access to home-based pregnancy tests - thus facilitating earlier resolution of the uncertainty of pregnancy status - influences such beliefs and decisions to take up family planning (FP).

The results will inform the design of a larger study in the future.
External Link(s)
Registration Citation
Kamei, Akito, Ryoko Sato and Rebecca Thornton. 2019. "Pregnancy Testing in Northern Uganda." AEA RCT Registry. May 11.
Former Citation
Kamei, Akito et al. 2019. "Pregnancy Testing in Northern Uganda." AEA RCT Registry. May 11.
Sponsors & Partners

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information
Experimental Details
Intervention Start Date
Intervention End Date
Primary Outcomes
Primary Outcomes (end points)
Use of any modern family planning method, perceived pregnancy status or degree of uncertainty about pregnancy status, and the value of pregnancy test (Willingness to pay).
Primary Outcomes (explanation)
We will construct measures for the following FP-related outcomes: use of any short-acting method and use of long-acting reversible method. Demand for pregnancy test kit is computed by Take it or leave it (TIOLI) method. We will also conduct sub-analyses among women who are not using modern family planning at baseline and women who are using modern family planning at baseline.
Secondary Outcomes
Secondary Outcomes (end points)
Secondary Outcomes (explanation)
Experimental Design
Experimental Design
Following baseline data collection, around 60% of the sample will be provided with a home pregnancy test to assess how resolving uncertainty about pregnancy status affects beliefs and behaviors.
Experimental Design Details
Not available
Randomization Method
Random number generator in the tablet.
Randomization Unit
Was the treatment clustered?
Experiment Characteristics
Sample size: planned number of clusters
No culster
Sample size: planned number of observations
1000 women - not pregnant or uncertain of pregnancy status, at risk of pregnancy.
Sample size (or number of clusters) by treatment arms
200 women, offer free pregnancy test at baseline
50 women, offer free pregnancy test at baseline and to keep for the future (free).
150 women, offer free pregnancy test at baseline and to keep for the future (with randomized price).
400 women, control group. No intervention.
50 women, offer free pregnancy test for the future.
150 women, offer pregnancy test to keep for the future (with randomized price).
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
According to the DHS 2016 in Uganda, 21.43% of people use modern short-term contraceptive (Injectable and Pills) in Ankole region (sample weighted). Following the power calculation of two proportion test, the treatment group has to have 29.57% take up of family planning with power set at 0.9. This is the 8.14 percentage points increase from the baseline.Our target sample size is 1,000 women. With 1,000 subjects, we can test various hypothesis as outlined below. Primarily, we compare 400 women who will be offered the pregnancy test under the treatment group and another 400 women in the control group who will not be offered the pregnancy test. The main outcome is the take-up of the modern family planning methods. This sample size of 800 women allows us to detect the standardized effect size 0.2 with power 0.8 and significance level 0.05. Assuming conservatively that the standard error is 0.5, we expect the treatment effect is 10 percentage points increase in the family planning take-up. We will additionally test if the previous experience of pregnancy test affects the willingness to pay for the pregnancy test, among 400 women (200 in treatment and 200 in control). This sample size allows us to detect the standardized effect size 0.28. Although this is a pilot study to test out the hypothesis using the small sample, we plan to scale-up in the future using the sufficient sample size, should we see any potential effect through this pilot study.
IRB Name
Gulu University Research Ethics Committee
IRB Approval Date
IRB Approval Number
IRB Name
University of Illinois at Urbana-Champaign Institutional Review Board
IRB Approval Date
IRB Approval Number